Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism

OBJECTIVES: To investigate the efficacy and safety of initial thrombolysis by recombinant tissue-type plasminogen activator (rt-PA) in compared with anticoagulant therapy in patients with acute intermediate-risk pulmonary embolism (PE). METHODS: Sixty-six patients with acute intermediate-risk PE wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ling-Yun, Gao, Bao-An, Jin, Zhu, Xiang, Guang-Ming, Gong, Zheng, Zhang, Ting-Ting, Lu, Hong-Fang, Wang, Yong-Quan, Gong, Yuan, Lu, Cheng, Huang, Wei-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274653/
https://www.ncbi.nlm.nih.gov/pubmed/30397707
http://dx.doi.org/10.15537/smj.2018.11.22717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274653/
https://www.ncbi.nlm.nih.gov/pubmed/30397707
http://dx.doi.org/10.15537/smj.2018.11.22717

Ejemplares similares